Cost-Containment

BenefitsPRO and Imagine360 are conducting a brief survey on the relationships between employers and benefits advisors and the cost-containment strategies employers are implementing. We'd like your help!

The White House is cracking down on drugmakers that have raised the costs of their medications faster that the rate of inflation – another move in a series of price-fighting measures being rolled out under the Inflation Reduction Act.

Retaining talent is now a top priority for any business but workers whose employers offer a 401(k) retirement plan are on average 40% less likely to leave in their first year, according to Gusto economists.

Although Gov. Ron DeSantis signed the plan into law in 2019, it required federal review and approval by the FDA.

Cancer patients received letters from the prestigious Manhattan hospital in December claiming the insurer would soon drop their coverage, but there is now a tentative agreement in place to provide coverage through April 14.

A group of 19 senators sent a letter to the U.S. Department of Health and Human Services to rethink its appeal of a recent court decision permitting the use of copay accumulator programs that help patients pay for their drugs.

Six in 10 midsized business leaders expect increased revenue and sales, although these expectations are more tempered than in previous years.

Sens. Tim Kaine and Mark R. Warner, who both have championed to lower the cost of prescription drugs, applauded Sanofi, Novo Nordisk and Eli Lilly – the three major insulin manufacturers – for slashing prices, effective Jan. 1, 2024.